Cited by 344Lipid metabolism and disordersLipoproteins and Cardiovascular HealthParaoxonase enzyme and polymorphisms

The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.

Lipoprotein Lipase Mutations, Plasma Lipids and Lipoproteins, and Risk of Ischemic Heart Disease: A Meta-Analysis

Wittrup, Hans H., Tybjærg-Hansen, Anne, Nordestgaard, Børge G.·1999·Circulation

Open this paper in CoChat — free account

Abstract

Background —We assessed in meta-analyses the effect of the Gly188Glu, Asp9Asn, Asn291Ser, and Ser447Ter substitutions in lipoprotein lipase in the heterozygous state on lipid metabolism and risk of ischemic heart disease (same order used below). Methods and Results —In 29 separate studies, 20 903 white subjects were screened for ≥1 of these substitutions; each meta-analysis included only some of these individuals. In population-based studies, heterozygote frequencies ranged from 0.04% to 0.2%, 2% to 4%, 1% to 7%, and 17% to 22% for the respective substitutions. Postheparin plasma lipoprotein lipase activity decreased 53% (95% CI, 31% to 75%) (only 1 study), 30% (22% to 37%), and 22% (8% to 35%) and was unchanged at 4% (−10% to 19%), respectively. Plasma triglycerides increased 78% (95% CI, 64% to 92%), 20% (9% to 33%), and 31% (20% to 43%) and decreased 8% (4% to 11%), respectively. HDL cholesterol decreased 0.25 mmol/L (0.18 to 0.32), 0.08 mmol/L (0.04 to 0.12), and 0.12 mmol/L (0.10 to 0.15) and increased 0.04 mmol/L (0.02 to 0.06), respectively. Odds ratios for ischemic heart disease were 4.9 (95% CI, 1.2 to 20) (only 1 study), 1.4 (0.8 to 2.4), 1.2 (0.9 to 1.5), and 0.8 (0.7 to 1.0), respectively. Subgroup analysis indicated that women with the Asn291Ser substitution may have an increased risk of ischemic heart disease. Conclusions —These meta-analyses suggest that compared with noncarriers, carriers of the Gly188Glu, Asp9Asn, and Asn291Ser substitutions have an atherogenic lipoprotein profile, whereas carriers of the Ser447Ter substitution have a protective lipoprotein profile. Accordingly, risk of ischemic heart disease in heterozygous carriers is increased for Gly188Glu carriers; at most, the increase is borderline for Asp9Asn and Asn291Ser carriers; and risk is possibly decreased for Ser447Ter carriers.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.cir.99.22.2901

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies
Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706
Some Statistical Methods for Combining Experimental Results
Laird, N. M., & Mosteller, F. C. (1990) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300008916 · Cited by 564
Cochrane Collaboration Handbook
Mulrow, C. (1996) · Medical Entomology and Zoology · Cited by 403
High density lipoproteins and coronary heart disease
Barter, P. J., & Rye, K.-A. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05675-0 · Cited by 377
Selective Retention of VLDL, IDL, and LDL in the Arterial Intima of Genetically Hyperlipidemic Rabbits In Vivo: Molecular Size as a Determinant of Fractional Loss From the Intima–Inner Media
Nordestgaard, B. G., Wootton, R., & Lewis, B. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.4.534 · Cited by 334
Self-citation
Premature Atherosclerosis in Patients with Familial Chylomicronemia Caused by Mutations in the Lipoprotein Lipase Gene
Benlian, P., Gennes, J. L. D., Foubert, L., Zhang, H., Gagné, S., & Hayden, M. R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609193351203 · Cited by 296
Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome.
Brunzell, J. (1989) · Medical Entomology and Zoology · Cited by 285
A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis
Reymer, P. W. A., Gagné, E., Groenemeyer, B. E., Zhang, H., Forsyth, I., Jansen, H., Seidell, J. C., Kromhout, D., Lie, K. I., Kastelein, J., et al. (1995) · Nature Genetics · doi:10.1038/ng0595-28 · Cited by 239
Molecular pathobiology of the human lipoprotein lipase gene
Murthy, V., Julien, P., & Gagné, C. (1996) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(96)00005-8 · Cited by 178
Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.
Wilson, D. E., Emi, M., Iverius, P., Hata, A., Wu, L. L., Hillas, E., Williams, R. R., & Lalouel, J.-M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114770 · Cited by 164
Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis
Fisher, R. M., Humphries, S. E., & Talmud, P. J. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00199-8 · Cited by 159
A Common Variant in the Gene for Lipoprotein Lipase (Asp9→Asn)
Mailly, F., Tugrul, Y., Reymer, P. W. A., Bruin, T., Seed, M., Groenemeyer, B. F., Asplund-Carlson, A., Vallance, D. T., WINDER, A. F., Miller, G. J., et al. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.4.468 · Cited by 153
Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Témoin sur l'Infarctus du Myocarde.
Jemaa, R., Fumeron, F., Poirier, O., Lecerf, L., Evans, A., Arveiler, D., Luc, G., Cambou, J., Bard, J., & Fruchart, J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39198-7 · Cited by 152
Heterozygous Lipoprotein Lipase Deficiency: Frequency in the General Population, Effect on Plasma Lipid Levels, and Risk of Ischemic Heart Disease
Nordestgaard, B. G., Abildgaard, S., Wittrup, H. H., Steffensen, R., Jensen, G., & Tybjærg-Hansen, A. (1997) · Circulation · doi:10.1161/01.cir.96.6.1737 · Cited by 146
Self-citation
DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population.
Mattu, R. K., Needham, E. W. A., Morgan, R., Rees, A., Hackshaw, A. K., Stocks, J., Elwood, P. C., & Galton, D. J. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.7.1090 · Cited by 140
Genetic Variant Showing a Positive Interaction With β-Blocking Agents With a Beneficial Influence on Lipoprotein Lipase Activity, HDL Cholesterol, and Triglyceride Levels in Coronary Artery Disease Patients
Groenemeijer, B. E., Hallman, M. D., Reymer, P. W. A., Gagné, E., Kuivenhoven, J. A., Bruin, T., Jansen, H., Lie, K. I., Bruschke, A. V. G., Boerwinkle, E., et al. (1997) · Circulation · doi:10.1161/01.cir.95.12.2628 · Cited by 137
Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden
Peacock, R. E., Hamsten, A., Nilsson‐Ehle, P., & Humphries, S. E. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90130-9 · Cited by 131
The Asp 9 Asn Mutation in the Lipoprotein Lipase Gene Is Associated With Increased Progression of Coronary Atherosclerosis
Jukema, J. W., Boven, A. J. V., Groenemeijer, B. E., Zwinderman, A. H., Reiber, J. H. C., Bruschke, A. V. G., Henneman, J. A., Molhoek, G. P., Bruin, T., Jansen, H., et al. (1996) · Circulation · doi:10.1161/01.cir.94.8.1913 · Cited by 123
A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease.
Wittrup, H. H., Tybjærg‐Hansen, A., Abildgaard, S., Steffensen, R., Schnohr, P., & Nordestgaard, B. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119323 · Cited by 114
Self-citation
A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity.
Yang, W. S., Nevin, D. N., Peng, R., Brunzell, J. D., & Deeb, S. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4462 · Cited by 108
Lipoprotein Lipase Variants D9N and N291S Are Associated With Increased Plasma Triglyceride and Lower High-Density Lipoprotein Cholesterol Concentrations
Gerdes, C., Fisher, R. M., Nicaud, V., Boer, J. M. A., Humphries, S. E., Talmud, P. J., & Færgeman, O. (1997) · Circulation · doi:10.1161/01.cir.96.3.733 · Cited by 103
Lipoprotein lipase genotypes for a common premature termination codon mutation detected by PCR-mediated site-directed mutagenesis and restriction digestion.
Stocks, J., Thorn, J. A., & Galton, D. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41510-x · Cited by 100
A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia
Reymer, P. W. A., Groenemeyer, B. E., Gagné, E., Li, M., Appelman, E. E. G., Seidel, J. C., Kromhout, D., Bijvoet, S. M., van den Oever, K., Bruin, T., et al. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.9.1543 · Cited by 90
Interaction of the lipoprotein lipase asparagine 291–>serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults.
Fisher, R. M., Mailly, F., Peacock, R. E., Hamsten, A., Seed, M., Yudkin, J. S., Beisiegel†, U., Feussner, G., Miller, G. J., & Humphries, S. E. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39195-1 · Cited by 82
Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies
Hokanson, J. E. (1997) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02827239 · Cited by 80
The lipoprotein lipase (Asn291 → Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia
Hoffer, M. J. V., Bredie, S. J. H., Boomsma, D. I., Reymer, P. W. A., Kastelein, J. J. P., de Knijff, P., Demacker, P. N. M., Stalenhoef, A. F. H., Havekes, L. M., & Frants, R. R. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05641-6 · Cited by 71
Patients With ApoE3 Deficiency (E2/2, E3/2, and E4/2) Who Manifest With Hyperlipidemia Have Increased Frequency of an Asn 291→Ser Mutation in the Human LPL Gene
Zhang, H., Reymer, P. W. A., Liu, M.-S., Forsythe, I. J., Groenemeyer, B. E., Frohlich, J. J., Brunzell, J. D., Kastelein, J. J. P., Hayden, M. R., & Ma, Y. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.10.1695 · Cited by 68
Combined effects of lipoprotein lipase and apolipoprotein E polymorphisms on lipid and lipoprotein levels in the Stanislas cohort
Salah, D., Bohnet, K., Gueguen, R., Siest, G., & Visvikis‐Siest, S. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37215-1 · Cited by 68
Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia
de Bruin, T. W., Mailly, F., van Barlingen, H. H. J. J., Fisher, R. M., Cabezas, M. C., Talmud, P. J., Dallinga‐Thie, G. M., & Humphries, S. E. (1996) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1996.tb02146.x · Cited by 67
A Common Mutation in the Lipoprotein Lipase Gene Promoter, −93T/G, Is Associated With Lower Plasma Triglyceride Levels and Increased Promoter Activity In Vitro
Hall, S., Chu, G., Miller, G. J., Cruickshank, K. J., Cooper, J. A., Humphries, S. E., & Talmud, P. J. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.1969 · Cited by 55
Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM study
Mailly, F., Fisher, R. M., Nicaud, V., Luong, L. A., Evans, A. E., Marques-Vidal, P. M., Luc, G., Arveiler, D., Bard, J., Poirier, O., et al. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05736-6 · Cited by 54
A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers.
Pimstone, S. N., Clee, S. M., Gagné, S., Li, M., Zhang, H., Stein, E. A., & Hayden, M. R. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39110-0 · Cited by 51
Common genetic variants of lipoprotein lipase that relate to lipid transport in patients with premature coronary artery disease
Zhang, Q., Cavanna, J., Winkelmann, B., Shine, B. S. F., Gross, W., März, W., & Galton, D. J. (1995) · Clinical Genetics · doi:10.1111/j.1399-0004.1995.tb04112.x · Cited by 47
Mutations in the Gene for Lipoprotein Lipase
Pimstone, S. N., Gagné, S., Gagné, C., Lupien, P. J., Gaudet, D., Williams, R. R., Kotze, M. J., Reymer, P. W. A., Defesche, J. C., Kastelein, J. J. P., et al. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.10.1704 · Cited by 44
Molecular basis of lipoprotein lipase deficiency in two Austrian families with type I hyperlipoproteinemia
Paulweber, B., Wiebusch, H., Miesenboeck, G., Funke, H., Assmann, G., Hölzl, B., Sippl, M. J., Friedl, W., Patsch, J. R., & Sandhofer, F. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90220-w · Cited by 36
Heterozygosity for Asn291–>Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia
Syvänne, M., Antikainen, M., Ehnholm, S., Tenkanen, H., Lahdenperä, S., Ehnholm, C., & Taskinen, M. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37571-4 · Cited by 31
Higher Triglycerides, Lower High-Density Lipoprotein Cholesterol, and Higher Systolic Blood Pressure in Lipoprotein Lipase–Deficient Heterozygotes
Sprecher, D. L., Harris, B. V., Stein, E. A., Bellet, P. S., Keilson, L., & Simbartl, L. A. (1996) · Circulation · doi:10.1161/01.cir.94.12.3239 · Cited by 30
The Asn‐291→Ser and Ser‐477→Stop mutations of the lipoprotein lipase gene and their significance for lipid metabolism in patients with hypertriglyceridaemia
Knudsen, P., Murtomäki-Repo, S., Antikainen, M., Ehnholm, S., Lahdenperä, S., Ehnholm, C., & Taskinen, M. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.2190767.x · Cited by 29
Molecular screening of the lipoprotein lipase gene in hypertriglyceridemic members of familial noninsulin-dependent diabetes mellitus families
Elbein, S. C., Yeager, C., Kwong, L. K., Lingam, A. T., Inoue, I., Lalouel, J.-M., & Wilson, D. E. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962342 · Cited by 25
Identification of putative beneficial mutations for lipid transport.
Galton, D. J., Mattu, R. K., Needham, E. W. A., & Cavanna, J. (1996) · PubMed · Cited by 18
Common genetic determinants of dyslipidemia: the hypertriglyceridemia/low-high-density lipoprotein syndrome.
Galton, D. J. (1995) · PubMed · Cited by 9
Common Genetic Determinants of Dyslipidemia
Galton, D. J. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199506001-00007 · Cited by 6

Research works printed but not linked: 13

10.1161/circ.96.3.733 · DOI
10.1161/circ.95.12.2628 · DOI
10.1161/atvb.15.4.468 · DOI
10.1161/atv91.14.7.7912549 · DOI
10.1161/atvb.15.10.1704 · DOI
10.1161/circ.94.12.3239 · DOI
10.1161/circ.96.6.1737 · DOI
10.1161/circ.94.8.1913 · DOI
10.1161/atvb.15.10.1695 · DOI
Jemaa R, Fumeron F, Poirier O, Lecerf L, Evans A, Arveiler D, Luc G, Cambou JP, Bard JM, Fruchart JC, Apfelbaum, Cambien F, Tiret L. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels: the ECTIM study. J Lipid Res. 1995;36:2141–2146.
Armitage P Berry G eds. Statistical Methods in Medical Research. Oxford UK: Blackwell Science Ltd; 1994:66–71 85–88 301–311 527–528 560–561.
10.1161/atvb.15.4.534 · DOI
10.1161/atvb.17.10.1969 · DOI

Sorted by citations

Atherosclerosis
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Self-citation
Role of Low Energy Expenditure and Sitting in Obesity, Metabolic Syndrome, Type 2 Diabetes, and Cardiovascular Disease
Hamilton, M. T., Hamilton, D. G., & Zderic, T. W. (2007) · Diabetes · doi:10.2337/db07-0882 · Cited by 1,655
Triglycerides and cardiovascular disease
Nordestgaard, B. G., & Varbo, A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61177-6 · Cited by 1,419
Self-citation
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227
Self-citation

See all 344

Authors: Wittrup, H. H., Tybjærg-Hansen, A., & Nordestgaard, B. G.
Affiliations: Herlev Hospital (DK)
From the Department of Clinical Biochemistry, Herlev University Hospital (H.H.W., A.T.-H.), Herlev, Denmark, and Department of Clinical Biochemistry, Glostrup University Hospital (B.G.N.), Glostrup, Denmark.
ORCID: Nordestgaard, Børge G.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1999-06-08
Volume: 99
Issue: 22
Pages: 2901-2907
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.99.22.2901
OpenAlex: W2011468836
Cited by: 344
References: 45
Citations by year: 2026: 2 · 2025: 8 · 2024: 4 · 2023: 1 · 2022: 6 · 2021: 5 · 2020: 4 · 2019: 5 · 2018: 4 · 2017: 11 · 2016: 17 · 2015: 13 · 2014: 11 · 2013: 12 · 2012: 11
FWCI: 3.64
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: Hjerteforeningen
Sundhed og Sygdom, Det Frie Forskningsråd
Medical Research Council
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: lipoprotein lipase, heterozygous carriers, ischemic heart disease risk, plasma triglycerides, HDL cholesterol, lipid metabolism, sex differences, genetic susceptibility
MeSH terms: Apolipoproteins B, Cholesterol, Cross-Sectional Studies, Female, Heparin, Humans, Lipids, Lipoprotein Lipase, Lipoproteins, Cholesterol, HDL, Male, Mutation, Risk Factors, Triglycerides, Case-Control Studies, Apolipoprotein A-I, Myocardial Ischemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Lipoprotein Lipase Mutations, Plasma Lipids and Lipoproteins, and Risk of Ischemic Heart Disease: A Meta-Analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks